Global Chronic Heart Failure (CHF) Devices Market Growth 2020-2025
According to this study, over the next five years the Chronic Heart Failure (CHF) Devices market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Chronic Heart Failure (CHF) Devices business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Chronic Heart Failure (CHF) Devices market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Chronic Heart Failure (CHF) Devices, covering the supply chain analysis, impact assessment to the Chronic Heart Failure (CHF) Devices market size growth rate in several scenarios, and the measures to be undertaken by Chronic Heart Failure (CHF) Devices companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Implantable Left Ventricular Assist Device (LVAD)
Biventricular Pacemaker
Implantable Cardioverter-defibrillators (ICDs)
Continuous Positive Air Pressure Device (CPAP)
Bi-level Positive Air Pressure Device (BiPAP)
Heart Pumps
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Clinic
Household
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Medtronic
Symplmed Pharmaceuticals
Abbott
Stanley Pharmaceuticals
New Haven Pharmaceuticals, Inc.
Johnson & Johnson
Biovail Corporation
Boston Scientific Corporation
Abiomed
HeartWare
Berlin Heart GmbH
Biotronik
Cardiokinetix
Jarvik Heart
ReliantHeart, Inc.
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Chronic Heart Failure (CHF) Devices consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Chronic Heart Failure (CHF) Devices market by identifying its various subsegments.
Focuses on the key global Chronic Heart Failure (CHF) Devices manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Chronic Heart Failure (CHF) Devices with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Chronic Heart Failure (CHF) Devices submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Chronic Heart Failure (CHF) Devices Consumption 2015-2025
2.1.2 Chronic Heart Failure (CHF) Devices Consumption CAGR by Region
2.2 Chronic Heart Failure (CHF) Devices Segment by Type
2.2.1 Implantable Left Ventricular Assist Device (LVAD)
2.2.2 Biventricular Pacemaker
2.2.3 Implantable Cardioverter-defibrillators (ICDs)
2.2.4 Continuous Positive Air Pressure Device (CPAP)
2.2.5 Bi-level Positive Air Pressure Device (BiPAP)
2.2.6 Heart Pumps
2.3 Chronic Heart Failure (CHF) Devices Consumption by Type
2.3.1 Global Chronic Heart Failure (CHF) Devices Consumption Market Share by Type (2015-2020)
2.3.2 Global Chronic Heart Failure (CHF) Devices Revenue and Market Share by Type (2015-2020)
2.3.3 Global Chronic Heart Failure (CHF) Devices Sale Price by Type (2015-2020)
2.4 Chronic Heart Failure (CHF) Devices Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Household
2.4.4 Others
2.5 Chronic Heart Failure (CHF) Devices Consumption by Application
2.5.1 Global Chronic Heart Failure (CHF) Devices Consumption Market Share by Type (2015-2020)
2.5.2 Global Chronic Heart Failure (CHF) Devices Value and Market Share by Type (2015-2020)
2.5.3 Global Chronic Heart Failure (CHF) Devices Sale Price by Type (2015-2020)
3 Global Chronic Heart Failure (CHF) Devices by Company
3.1 Global Chronic Heart Failure (CHF) Devices Sales Market Share by Company
3.1.1 Global Chronic Heart Failure (CHF) Devices Sales by Company (2018-2020)
3.1.2 Global Chronic Heart Failure (CHF) Devices Sales Market Share by Company (2018-2020)
3.2 Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Company
3.2.1 Global Chronic Heart Failure (CHF) Devices Revenue by Company (2018-2020)
3.2.2 Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Company (2018-2020)
3.3 Global Chronic Heart Failure (CHF) Devices Sale Price by Company
3.4 Global Chronic Heart Failure (CHF) Devices Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Chronic Heart Failure (CHF) Devices Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Chronic Heart Failure (CHF) Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Chronic Heart Failure (CHF) Devices by Regions
4.1 Chronic Heart Failure (CHF) Devices by Regions
4.2 Americas Chronic Heart Failure (CHF) Devices Consumption Growth
4.3 APAC Chronic Heart Failure (CHF) Devices Consumption Growth
4.4 Europe Chronic Heart Failure (CHF) Devices Consumption Growth
4.5 Middle East & Africa Chronic Heart Failure (CHF) Devices Consumption Growth
5 Americas
5.1 Americas Chronic Heart Failure (CHF) Devices Consumption by Countries
5.1.1 Americas Chronic Heart Failure (CHF) Devices Consumption by Countries (2015-2020)
5.1.2 Americas Chronic Heart Failure (CHF) Devices Value by Countries (2015-2020)
5.2 Americas Chronic Heart Failure (CHF) Devices Consumption by Type
5.3 Americas Chronic Heart Failure (CHF) Devices Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Chronic Heart Failure (CHF) Devices Consumption by Regions
6.1.1 APAC Chronic Heart Failure (CHF) Devices Consumption by Regions (2015-2020)
6.1.2 APAC Chronic Heart Failure (CHF) Devices Value by Regions (2015-2020)
6.2 APAC Chronic Heart Failure (CHF) Devices Consumption by Type
6.3 APAC Chronic Heart Failure (CHF) Devices Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Chronic Heart Failure (CHF) Devices by Countries
7.1.1 Europe Chronic Heart Failure (CHF) Devices Consumption by Countries (2015-2020)
7.1.2 Europe Chronic Heart Failure (CHF) Devices Value by Countries (2015-2020)
7.2 Europe Chronic Heart Failure (CHF) Devices Consumption by Type
7.3 Europe Chronic Heart Failure (CHF) Devices Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Chronic Heart Failure (CHF) Devices by Countries
8.1.1 Middle East & Africa Chronic Heart Failure (CHF) Devices Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Chronic Heart Failure (CHF) Devices Value by Countries (2015-2020)
8.2 Middle East & Africa Chronic Heart Failure (CHF) Devices Consumption by Type
8.3 Middle East & Africa Chronic Heart Failure (CHF) Devices Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Chronic Heart Failure (CHF) Devices Distributors
10.3 Chronic Heart Failure (CHF) Devices Customer
11 Global Chronic Heart Failure (CHF) Devices Market Forecast
11.1 Global Chronic Heart Failure (CHF) Devices Consumption Forecast (2021-2025)
11.2 Global Chronic Heart Failure (CHF) Devices Forecast by Regions
11.2.1 Global Chronic Heart Failure (CHF) Devices Forecast by Regions (2021-2025)
11.2.2 Global Chronic Heart Failure (CHF) Devices Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Chronic Heart Failure (CHF) Devices Forecast by Type
11.8 Global Chronic Heart Failure (CHF) Devices Forecast by Application
12 Key Players Analysis
12.1 Medtronic
12.1.1 Company Information
12.1.2 Chronic Heart Failure (CHF) Devices Product Offered
12.1.3 Medtronic Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Medtronic Latest Developments
12.2 Symplmed Pharmaceuticals
12.2.1 Company Information
12.2.2 Chronic Heart Failure (CHF) Devices Product Offered
12.2.3 Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Symplmed Pharmaceuticals Latest Developments
12.3 Abbott
12.3.1 Company Information
12.3.2 Chronic Heart Failure (CHF) Devices Product Offered
12.3.3 Abbott Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Abbott Latest Developments
12.4 Stanley Pharmaceuticals
12.4.1 Company Information
12.4.2 Chronic Heart Failure (CHF) Devices Product Offered
12.4.3 Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Stanley Pharmaceuticals Latest Developments
12.5 New Haven Pharmaceuticals, Inc.
12.5.1 Company Information
12.5.2 Chronic Heart Failure (CHF) Devices Product Offered
12.5.3 New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 New Haven Pharmaceuticals, Inc. Latest Developments
12.6 Johnson & Johnson
12.6.1 Company Information
12.6.2 Chronic Heart Failure (CHF) Devices Product Offered
12.6.3 Johnson & Johnson Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Johnson & Johnson Latest Developments
12.7 Biovail Corporation
12.7.1 Company Information
12.7.2 Chronic Heart Failure (CHF) Devices Product Offered
12.7.3 Biovail Corporation Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Biovail Corporation Latest Developments
12.8 Boston Scientific Corporation
12.8.1 Company Information
12.8.2 Chronic Heart Failure (CHF) Devices Product Offered
12.8.3 Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Boston Scientific Corporation Latest Developments
12.9 Abiomed
12.9.1 Company Information
12.9.2 Chronic Heart Failure (CHF) Devices Product Offered
12.9.3 Abiomed Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Abiomed Latest Developments
12.10 HeartWare
12.10.1 Company Information
12.10.2 Chronic Heart Failure (CHF) Devices Product Offered
12.10.3 HeartWare Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 HeartWare Latest Developments
12.11 Berlin Heart GmbH
12.11.1 Company Information
12.11.2 Chronic Heart Failure (CHF) Devices Product Offered
12.11.3 Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Berlin Heart GmbH Latest Developments
12.12 Biotronik
12.12.1 Company Information
12.12.2 Chronic Heart Failure (CHF) Devices Product Offered
12.12.3 Biotronik Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Biotronik Latest Developments
12.13 Cardiokinetix
12.13.1 Company Information
12.13.2 Chronic Heart Failure (CHF) Devices Product Offered
12.13.3 Cardiokinetix Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Cardiokinetix Latest Developments
12.14 Jarvik Heart
12.14.1 Company Information
12.14.2 Chronic Heart Failure (CHF) Devices Product Offered
12.14.3 Jarvik Heart Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Jarvik Heart Latest Developments
12.15 ReliantHeart, Inc.
12.15.1 Company Information
12.15.2 Chronic Heart Failure (CHF) Devices Product Offered
12.15.3 ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 ReliantHeart, Inc. Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Chronic Heart Failure (CHF) Devices Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Implantable Left Ventricular Assist Device (LVAD)
Table 5. Major Players of Biventricular Pacemaker
Table 6. Major Players of Implantable Cardioverter-defibrillators (ICDs)
Table 7. Major Players of Continuous Positive Air Pressure Device (CPAP)
Table 8. Major Players of Bi-level Positive Air Pressure Device (BiPAP)
Table 9. Major Players of Heart Pumps
Table 10. Global Consumption Sales by Type (2015-2020)
Table 11. Global Chronic Heart Failure (CHF) Devices Consumption Market Share by Type (2015-2020)
Table 12. Global Chronic Heart Failure (CHF) Devices Revenue by Type (2015-2020) ($ million)
Table 13. Global Chronic Heart Failure (CHF) Devices Value Market Share by Type (2015-2020) ($ Millions)
Table 14. Global Chronic Heart Failure (CHF) Devices Sale Price by Type (2015-2020)
Table 15. Global Consumption Sales by Application (2015-2020)
Table 16. Global Chronic Heart Failure (CHF) Devices Consumption Market Share by Application (2015-2020)
Table 17. Global Chronic Heart Failure (CHF) Devices Value by Application (2015-2020)
Table 18. Global Chronic Heart Failure (CHF) Devices Value Market Share by Application (2015-2020)
Table 19. Global Chronic Heart Failure (CHF) Devices Sale Price by Application (2015-2020)
Table 20. Global Chronic Heart Failure (CHF) Devices Sales by Company (2017-2019) (K Units)
Table 21. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Company (2017-2019)
Table 22. Global Chronic Heart Failure (CHF) Devices Revenue by Company (2017-2019) ($ Millions)
Table 23. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Company (2017-2019)
Table 24. Global Chronic Heart Failure (CHF) Devices Sale Price by Company (2017-2019)
Table 25. Global Chronic Heart Failure (CHF) Devices Manufacturing Base Distribution and Sales Area by Manufacturers
Table 26. Players Chronic Heart Failure (CHF) Devices Products Offered
Table 27. Chronic Heart Failure (CHF) Devices Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 28. Global Chronic Heart Failure (CHF) Devices Consumption by Regions 2015-2020 (K Units)
Table 29. Global Chronic Heart Failure (CHF) Devices Consumption Market Share by Regions 2015-2020
Table 30. Global Chronic Heart Failure (CHF) Devices Value by Regions 2015-2020 ($ Millions)
Table 31. Global Chronic Heart Failure (CHF) Devices Value Market Share by Regions 2015-2020
Table 32. Americas Chronic Heart Failure (CHF) Devices Consumption by Countries (2015-2020) (K Units)
Table 33. Americas Chronic Heart Failure (CHF) Devices Consumption Market Share by Countries (2015-2020)
Table 34. Americas Chronic Heart Failure (CHF) Devices Value by Countries (2015-2020) ($ Millions)
Table 35. Americas Chronic Heart Failure (CHF) Devices Value Market Share by Countries (2015-2020)
Table 36. Americas Chronic Heart Failure (CHF) Devices Consumption by Type (2015-2020) (K Units)
Table 37. Americas Chronic Heart Failure (CHF) Devices Consumption Market Share by Type (2015-2020)
Table 38. Americas Chronic Heart Failure (CHF) Devices Consumption by Application (2015-2020) (K Units)
Table 39. Americas Chronic Heart Failure (CHF) Devices Consumption Market Share by Application (2015-2020)
Table 40. APAC Chronic Heart Failure (CHF) Devices Consumption by Countries (2015-2020) (K Units)
Table 41. APAC Chronic Heart Failure (CHF) Devices Consumption Market Share by Countries (2015-2020)
Table 42. APAC Chronic Heart Failure (CHF) Devices Value by Regions (2015-2020) ($ Millions)
Table 43. APAC Chronic Heart Failure (CHF) Devices Value Market Share by Regions (2015-2020)
Table 44. APAC Chronic Heart Failure (CHF) Devices Consumption by Type (2015-2020) (K Units)
Table 45. APAC Chronic Heart Failure (CHF) Devices Consumption Market Share by Type (2015-2020)
Table 46. APAC Chronic Heart Failure (CHF) Devices Consumption by Application (2015-2020) (K Units)
Table 47. APAC Chronic Heart Failure (CHF) Devices Consumption Market Share by Application (2015-2020)
Table 48. Europe Chronic Heart Failure (CHF) Devices Consumption by Countries (2015-2020) (K Units)
Table 49. Europe Chronic Heart Failure (CHF) Devices Consumption Market Share by Countries (2015-2020)
Table 50. Europe Chronic Heart Failure (CHF) Devices Value by Countries (2015-2020) ($ Millions)
Table 51. Europe Chronic Heart Failure (CHF) Devices Value Market Share by Countries (2015-2020)
Table 52. Europe Chronic Heart Failure (CHF) Devices Consumption by Type (2015-2020) (K Units)
Table 53. Europe Chronic Heart Failure (CHF) Devices Consumption Market Share by Type (2015-2020)
Table 54. Europe Chronic Heart Failure (CHF) Devices Consumption by Application (2015-2020) (K Units)
Table 55. Europe Chronic Heart Failure (CHF) Devices Consumption Market Share by Application (2015-2020)
Table 56. Middle East & Africa Chronic Heart Failure (CHF) Devices Consumption by Countries (2015-2020) (K Units)
Table 57. Middle East & Africa Chronic Heart Failure (CHF) Devices Consumption Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Chronic Heart Failure (CHF) Devices Value by Countries (2015-2020) ($ Millions)
Table 59. Middle East & Africa Chronic Heart Failure (CHF) Devices Value Market Share by Countries (2015-2020)
Table 60. Middle East & Africa Chronic Heart Failure (CHF) Devices Consumption by Type (2015-2020) (K Units)
Table 61. Middle East & Africa Chronic Heart Failure (CHF) Devices Consumption Market Share by Type (2015-2020)
Table 62. Middle East & Africa Chronic Heart Failure (CHF) Devices Consumption by Application (2015-2020) (K Units)
Table 63. Middle East & Africa Chronic Heart Failure (CHF) Devices Consumption Market Share by Application (2015-2020)
Table 64. Chronic Heart Failure (CHF) Devices Distributors List
Table 65. Chronic Heart Failure (CHF) Devices Customer List
Table 66. Global Chronic Heart Failure (CHF) Devices Consumption Forecast by Countries (2021-2025) (K Units)
Table 67. Global Chronic Heart Failure (CHF) Devices Consumption Market Forecast by Regions
Table 68. Global Chronic Heart Failure (CHF) Devices Value Forecast by Countries (2021-2025) ($ Millions)
Table 69. Global Chronic Heart Failure (CHF) Devices Value Market Share Forecast by Regions
Table 70. Global Chronic Heart Failure (CHF) Devices Consumption Forecast by Type (2021-2025) (K Units)
Table 71. Global Chronic Heart Failure (CHF) Devices Consumption Market Share Forecast by Type (2021-2025)
Table 72. Global Chronic Heart Failure (CHF) Devices Value Forecast by Type (2021-2025) ($ Millions)
Table 73. Global Chronic Heart Failure (CHF) Devices Value Market Share Forecast by Type (2021-2025)
Table 74. Global Chronic Heart Failure (CHF) Devices Consumption Forecast by Application (2021-2025) (K Units)
Table 75. Global Chronic Heart Failure (CHF) Devices Consumption Market Share Forecast by Application (2021-2025)
Table 76. Global Chronic Heart Failure (CHF) Devices Value Forecast by Application (2021-2025) ($ Millions)
Table 77. Global Chronic Heart Failure (CHF) Devices Value Market Share Forecast by Application (2021-2025)
Table 78. Medtronic Product Offered
Table 79. Medtronic Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 80. Medtronic Main Business
Table 81. Medtronic Latest Developments
Table 82. Medtronic Basic Information, Company Total Revenue (in $ million), Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors
Table 83. Symplmed Pharmaceuticals Product Offered
Table 84. Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 85. Symplmed Pharmaceuticals Main Business
Table 86. Symplmed Pharmaceuticals Latest Developments
Table 87. Symplmed Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors
Table 88. Abbott Product Offered
Table 89. Abbott Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 90. Abbott Main Business
Table 91. Abbott Latest Developments
Table 92. Abbott Basic Information, Company Total Revenue (in $ million), Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors
Table 93. Stanley Pharmaceuticals Product Offered
Table 94. Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 95. Stanley Pharmaceuticals Main Business
Table 96. Stanley Pharmaceuticals Latest Developments
Table 97. Stanley Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors
Table 98. New Haven Pharmaceuticals, Inc. Product Offered
Table 99. New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 100. New Haven Pharmaceuticals, Inc. Main Business
Table 101. New Haven Pharmaceuticals, Inc. Latest Developments
Table 102. New Haven Pharmaceuticals, Inc. Basic Information, Company Total Revenue (in $ million), Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors
Table 103. Johnson & Johnson Product Offered
Table 104. Johnson & Johnson Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 105. Johnson & Johnson Main Business
Table 106. Johnson & Johnson Latest Developments
Table 107. Johnson & Johnson Basic Information, Company Total Revenue (in $ million), Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors
Table 108. Biovail Corporation Product Offered
Table 109. Biovail Corporation Basic Information, Company Total Revenue (in $ million), Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors
Table 110. Biovail Corporation Main Business
Table 111. Biovail Corporation Latest Developments
Table 112. Biovail Corporation Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 113. Boston Scientific Corporation Product Offered
Table 114. Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 115. Boston Scientific Corporation Main Business
Table 116. Boston Scientific Corporation Latest Developments
Table 117. Boston Scientific Corporation Basic Information, Company Total Revenue (in $ million), Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors
Table 118. Abiomed Product Offered
Table 119. Abiomed Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 120. Abiomed Main Business
Table 121. Abiomed Latest Developments
Table 122. Abiomed Basic Information, Company Total Revenue (in $ million), Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors
Table 123. HeartWare Product Offered
Table 124. HeartWare Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 125. HeartWare Main Business
Table 126. HeartWare Latest Developments
Table 127. HeartWare Basic Information, Company Total Revenue (in $ million), Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors
Table 128. Berlin Heart GmbH Product Offered
Table 129. Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 130. Berlin Heart GmbH Main Business
Table 131. Berlin Heart GmbH Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 132. Berlin Heart GmbH Latest Developments
Table 133. Biotronik Product Offered
Table 134. Biotronik Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 135. Biotronik Main Business
Table 136. Biotronik Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 137. Biotronik Latest Developments
Table 138. Cardiokinetix Product Offered
Table 139. Cardiokinetix Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 140. Cardiokinetix Main Business
Table 141. Cardiokinetix Latest Developments
Table 142. Cardiokinetix Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 143. Jarvik Heart Product Offered
Table 144. Jarvik Heart Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 145. Jarvik Heart Main Business
Table 146. Jarvik Heart Latest Developments
Table 147. Jarvik Heart Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 148. ReliantHeart, Inc. Product Offered
Table 149. ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 150. ReliantHeart, Inc. Main Business
Table 151. ReliantHeart, Inc. Latest Developments
Table 152. ReliantHeart, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Chronic Heart Failure (CHF) Devices
Figure 2. Chronic Heart Failure (CHF) Devices Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Chronic Heart Failure (CHF) Devices Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Chronic Heart Failure (CHF) Devices Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Implantable Left Ventricular Assist Device (LVAD)
Figure 7. Product Picture of Biventricular Pacemaker
Figure 8. Product Picture of Implantable Cardioverter-defibrillators (ICDs)
Figure 9. Product Picture of Continuous Positive Air Pressure Device (CPAP)
Figure 10. Product Picture of Bi-level Positive Air Pressure Device (BiPAP)
Figure 11. Product Picture of Heart Pumps
Figure 12. Global Chronic Heart Failure (CHF) Devices Consumption Market Share by Type (2015-2020)
Figure 13. Global Chronic Heart Failure (CHF) Devices Value Market Share by Type (2015-2020)
Figure 14. Chronic Heart Failure (CHF) Devices Consumed in Hospital
Figure 15. Global Chronic Heart Failure (CHF) Devices Market: Hospital (2015-2020) (K Units)
Figure 16. Global Chronic Heart Failure (CHF) Devices Market: Hospital (2015-2020) ($ Millions)
Figure 17. Chronic Heart Failure (CHF) Devices Consumed in Clinic
Figure 18. Global Chronic Heart Failure (CHF) Devices Market: Clinic (2015-2020) (K Units)
Figure 19. Global Chronic Heart Failure (CHF) Devices Market: Clinic (2015-2020) ($ Millions)
Figure 20. Chronic Heart Failure (CHF) Devices Consumed in Household
Figure 21. Global Chronic Heart Failure (CHF) Devices Market: Household (2015-2020) (K Units)
Figure 22. Global Chronic Heart Failure (CHF) Devices Market: Household (2015-2020) ($ Millions)
Figure 23. Chronic Heart Failure (CHF) Devices Consumed in Others
Figure 24. Global Chronic Heart Failure (CHF) Devices Market: Others (2015-2020) (K Units)
Figure 25. Global Chronic Heart Failure (CHF) Devices Market: Others (2015-2020) ($ Millions)
Figure 26. Global Chronic Heart Failure (CHF) Devices Consumption Market Share by Application (2015-2020)
Figure 27. Global Chronic Heart Failure (CHF) Devices Value Market Share by Application (2015-2020)
Figure 28. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Company in 2017
Figure 29. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Company in 2019
Figure 30. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Company in 2017
Figure 31. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Company in 2019
Figure 32. Global Chronic Heart Failure (CHF) Devices Sale Price by Company in 2019
Figure 33. Global Chronic Heart Failure (CHF) Devices Consumption Market Share by Regions 2015-2020
Figure 34. Global Chronic Heart Failure (CHF) Devices Value Market Share by Regions 2015-2020
Figure 35. Americas Chronic Heart Failure (CHF) Devices Consumption 2015-2020 (K Units)
Figure 36. Americas Chronic Heart Failure (CHF) Devices Value 2015-2020 ($ Millions)
Figure 37. APAC Chronic Heart Failure (CHF) Devices Consumption 2015-2020 (K Units)
Figure 38. APAC Chronic Heart Failure (CHF) Devices Value 2015-2020 ($ Millions)
Figure 39. Europe Chronic Heart Failure (CHF) Devices Consumption 2015-2020 (K Units)
Figure 40. Europe Chronic Heart Failure (CHF) Devices Value 2015-2020 ($ Millions)
Figure 41. Middle East & Africa Chronic Heart Failure (CHF) Devices Consumption 2015-2020 (K Units)
Figure 42. Middle East & Africa Chronic Heart Failure (CHF) Devices Value 2015-2020 ($ Millions)
Figure 43. Americas Chronic Heart Failure (CHF) Devices Consumption Market Share by Countries in 2019
Figure 44. Americas Chronic Heart Failure (CHF) Devices Value Market Share by Countries in 2019
Figure 45. Americas Chronic Heart Failure (CHF) Devices Consumption Market Share by Type in 2019
Figure 46. Americas Chronic Heart Failure (CHF) Devices Consumption Market Share by Application in 2019
Figure 47. United States Chronic Heart Failure (CHF) Devices Consumption Growth 2015-2020 (K Units)
Figure 48. United States Chronic Heart Failure (CHF) Devices Value Growth 2015-2020 ($ Millions)
Figure 49. Canada Chronic Heart Failure (CHF) Devices Consumption Growth 2015-2020 (K Units)
Figure 50. Canada Chronic Heart Failure (CHF) Devices Value Growth 2015-2020 ($ Millions)
Figure 51. Mexico Chronic Heart Failure (CHF) Devices Consumption Growth 2015-2020 (K Units)
Figure 52. Mexico Chronic Heart Failure (CHF) Devices Value Growth 2015-2020 ($ Millions)
Figure 53. APAC Chronic Heart Failure (CHF) Devices Consumption Market Share by Countries in 2019
Figure 54. APAC Chronic Heart Failure (CHF) Devices Value Market Share by Regions in 2019
Figure 55. APAC Chronic Heart Failure (CHF) Devices Consumption Market Share by Type in 2019
Figure 56. APAC Chronic Heart Failure (CHF) Devices Consumption Market Share by Application in 2019
Figure 57. China Chronic Heart Failure (CHF) Devices Consumption Growth 2015-2020 (K Units)
Figure 58. China Chronic Heart Failure (CHF) Devices Value Growth 2015-2020 ($ Millions)
Figure 59. Japan Chronic Heart Failure (CHF) Devices Consumption Growth 2015-2020 (K Units)
Figure 60. Japan Chronic Heart Failure (CHF) Devices Value Growth 2015-2020 ($ Millions)
Figure 61. Korea Chronic Heart Failure (CHF) Devices Consumption Growth 2015-2020 (K Units)
Figure 62. Korea Chronic Heart Failure (CHF) Devices Value Growth 2015-2020 ($ Millions)
Figure 63. Southeast Asia Chronic Heart Failure (CHF) Devices Consumption Growth 2015-2020 (K Units)
Figure 64. Southeast Asia Chronic Heart Failure (CHF) Devices Value Growth 2015-2020 ($ Millions)
Figure 65. India Chronic Heart Failure (CHF) Devices Consumption Growth 2015-2020 (K Units)
Figure 66. India Chronic Heart Failure (CHF) Devices Value Growth 2015-2020 ($ Millions)
Figure 67. Australia Chronic Heart Failure (CHF) Devices Consumption Growth 2015-2020 (K Units)
Figure 68. Australia Chronic Heart Failure (CHF) Devices Value Growth 2015-2020 ($ Millions)
Figure 69. Europe Chronic Heart Failure (CHF) Devices Consumption Market Share by Countries in 2019
Figure 70. Europe Chronic Heart Failure (CHF) Devices Value Market Share by Countries in 2019
Figure 71. Europe Chronic Heart Failure (CHF) Devices Consumption Market Share by Type in 2019
Figure 72. Europe Chronic Heart Failure (CHF) Devices Consumption Market Share by Application in 2019
Figure 73. Germany Chronic Heart Failure (CHF) Devices Consumption Growth 2015-2020 (K Units)
Figure 74. Germany Chronic Heart Failure (CHF) Devices Value Growth 2015-2020 ($ Millions)
Figure 75. France Chronic Heart Failure (CHF) Devices Consumption Growth 2015-2020 (K Units)
Figure 76. France Chronic Heart Failure (CHF) Devices Value Growth 2015-2020 ($ Millions)
Figure 77. UK Chronic Heart Failure (CHF) Devices Consumption Growth 2015-2020 (K Units)
Figure 78. UK Chronic Heart Failure (CHF) Devices Value Growth 2015-2020 ($ Millions)
Figure 79. Italy Chronic Heart Failure (CHF) Devices Consumption Growth 2015-2020 (K Units)
Figure 80. Italy Chronic Heart Failure (CHF) Devices Value Growth 2015-2020 ($ Millions)
Figure 81. Russia Chronic Heart Failure (CHF) Devices Consumption Growth 2015-2020 (K Units)
Figure 82. Russia Chronic Heart Failure (CHF) Devices Value Growth 2015-2020 ($ Millions)
Figure 83. Middle East & Africa Chronic Heart Failure (CHF) Devices Consumption Market Share by Countries in 2019
Figure 84. Middle East & Africa Chronic Heart Failure (CHF) Devices Value Market Share by Countries in 2019
Figure 85. Middle East & Africa Chronic Heart Failure (CHF) Devices Consumption Market Share by Type in 2019
Figure 86. Middle East & Africa Chronic Heart Failure (CHF) Devices Consumption Market Share by Application in 2019
Figure 87. Egypt Chronic Heart Failure (CHF) Devices Consumption Growth 2015-2020 (K Units)
Figure 88. Egypt Chronic Heart Failure (CHF) Devices Value Growth 2015-2020 ($ Millions)
Figure 89. South Africa Chronic Heart Failure (CHF) Devices Consumption Growth 2015-2020 (K Units)
Figure 90. South Africa Chronic Heart Failure (CHF) Devices Value Growth 2015-2020 ($ Millions)
Figure 91. Israel Chronic Heart Failure (CHF) Devices Consumption Growth 2015-2020 (K Units)
Figure 92. Israel Chronic Heart Failure (CHF) Devices Value Growth 2015-2020 ($ Millions)
Figure 93. Turkey Chronic Heart Failure (CHF) Devices Consumption Growth 2015-2020 (K Units)
Figure 94. Turkey Chronic Heart Failure (CHF) Devices Value Growth 2015-2020 ($ Millions)
Figure 95. GCC Countries Chronic Heart Failure (CHF) Devices Consumption Growth 2015-2020 (K Units)
Figure 96. GCC Countries Chronic Heart Failure (CHF) Devices Value Growth 2015-2020 ($ Millions)
Figure 97. Global Chronic Heart Failure (CHF) Devices Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 98. Global Chronic Heart Failure (CHF) Devices Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 99. Americas Chronic Heart Failure (CHF) Devices Consumption 2021-2025 (K Units)
Figure 100. Americas Chronic Heart Failure (CHF) Devices Value 2021-2025 ($ Millions)
Figure 101. APAC Chronic Heart Failure (CHF) Devices Consumption 2021-2025 (K Units)
Figure 102. APAC Chronic Heart Failure (CHF) Devices Value 2021-2025 ($ Millions)
Figure 103. Europe Chronic Heart Failure (CHF) Devices Consumption 2021-2025 (K Units)
Figure 104. Europe Chronic Heart Failure (CHF) Devices Value 2021-2025 ($ Millions)
Figure 105. Middle East & Africa Chronic Heart Failure (CHF) Devices Consumption 2021-2025 (K Units)
Figure 106. Middle East & Africa Chronic Heart Failure (CHF) Devices Value 2021-2025 ($ Millions)
Figure 107. United States Chronic Heart Failure (CHF) Devices Consumption 2021-2025 (K Units)
Figure 108. United States Chronic Heart Failure (CHF) Devices Value 2021-2025 ($ Millions)
Figure 109. Canada Chronic Heart Failure (CHF) Devices Consumption 2021-2025 (K Units)
Figure 110. Canada Chronic Heart Failure (CHF) Devices Value 2021-2025 ($ Millions)
Figure 111. Mexico Chronic Heart Failure (CHF) Devices Consumption 2021-2025 (K Units)
Figure 112. Mexico Chronic Heart Failure (CHF) Devices Value 2021-2025 ($ Millions)
Figure 113. Brazil Chronic Heart Failure (CHF) Devices Consumption 2021-2025 (K Units)
Figure 114. Brazil Chronic Heart Failure (CHF) Devices Value 2021-2025 ($ Millions)
Figure 115. China Chronic Heart Failure (CHF) Devices Consumption 2021-2025 (K Units)
Figure 116. China Chronic Heart Failure (CHF) Devices Value 2021-2025 ($ Millions)
Figure 117. Japan Chronic Heart Failure (CHF) Devices Consumption 2021-2025 (K Units)
Figure 118. Japan Chronic Heart Failure (CHF) Devices Value 2021-2025 ($ Millions)
Figure 119. Korea Chronic Heart Failure (CHF) Devices Consumption 2021-2025 (K Units)
Figure 120. Korea Chronic Heart Failure (CHF) Devices Value 2021-2025 ($ Millions)
Figure 121. Southeast Asia Chronic Heart Failure (CHF) Devices Consumption 2021-2025 (K Units)
Figure 122. Southeast Asia Chronic Heart Failure (CHF) Devices Value 2021-2025 ($ Millions)
Figure 123. India Chronic Heart Failure (CHF) Devices Consumption 2021-2025 (K Units)
Figure 124. India Chronic Heart Failure (CHF) Devices Value 2021-2025 ($ Millions)
Figure 125. Australia Chronic Heart Failure (CHF) Devices Consumption 2021-2025 (K Units)
Figure 126. Australia Chronic Heart Failure (CHF) Devices Value 2021-2025 ($ Millions)
Figure 127. Germany Chronic Heart Failure (CHF) Devices Consumption 2021-2025 (K Units)
Figure 128. Germany Chronic Heart Failure (CHF) Devices Value 2021-2025 ($ Millions)
Figure 129. France Chronic Heart Failure (CHF) Devices Consumption 2021-2025 (K Units)
Figure 130. France Chronic Heart Failure (CHF) Devices Value 2021-2025 ($ Millions)
Figure 131. UK Chronic Heart Failure (CHF) Devices Consumption 2021-2025 (K Units)
Figure 132. UK Chronic Heart Failure (CHF) Devices Value 2021-2025 ($ Millions)
Figure 133. Italy Chronic Heart Failure (CHF) Devices Consumption 2021-2025 (K Units)
Figure 134. Italy Chronic Heart Failure (CHF) Devices Value 2021-2025 ($ Millions)
Figure 135. Russia Chronic Heart Failure (CHF) Devices Consumption 2021-2025 (K Units)
Figure 136. Russia Chronic Heart Failure (CHF) Devices Value 2021-2025 ($ Millions)
Figure 137. Spain Chronic Heart Failure (CHF) Devices Consumption 2021-2025 (K Units)
Figure 138. Spain Chronic Heart Failure (CHF) Devices Value 2021-2025 ($ Millions)
Figure 139. Egypt Chronic Heart Failure (CHF) Devices Consumption 2021-2025 (K Units)
Figure 140. Egypt Chronic Heart Failure (CHF) Devices Value 2021-2025 ($ Millions)
Figure 141. South Africa Chronic Heart Failure (CHF) Devices Consumption 2021-2025 (K Units)
Figure 142. South Africa Chronic Heart Failure (CHF) Devices Value 2021-2025 ($ Millions)
Figure 143. Israel Chronic Heart Failure (CHF) Devices Consumption 2021-2025 (K Units)
Figure 144. Israel Chronic Heart Failure (CHF) Devices Value 2021-2025 ($ Millions)
Figure 145. Turkey Chronic Heart Failure (CHF) Devices Consumption 2021-2025 (K Units)
Figure 146. Turkey Chronic Heart Failure (CHF) Devices Value 2021-2025 ($ Millions)
Figure 147. GCC Countries Chronic Heart Failure (CHF) Devices Consumption 2021-2025 (K Units)
Figure 148. GCC Countries Chronic Heart Failure (CHF) Devices Value 2021-2025 ($ Millions)
Figure 149. Medtronic Chronic Heart Failure (CHF) Devices Market Share (2018-2020)
Figure 150. Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Market Share (2018-2020)
Figure 151. Abbott Chronic Heart Failure (CHF) Devices Market Share (2018-2020)
Figure 152. Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Market Share (2018-2020)
Figure 153. New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Market Share (2018-2020)
Figure 154. Johnson & Johnson Chronic Heart Failure (CHF) Devices Market Share (2018-2020)
Figure 155. Biovail Corporation Chronic Heart Failure (CHF) Devices Market Share (2018-2020)
Figure 156. Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Market Share (2018-2020)
Figure 157. Abiomed Chronic Heart Failure (CHF) Devices Market Share (2018-2020)
Figure 158. HeartWare Chronic Heart Failure (CHF) Devices Market Share (2018-2020)
Figure 159. Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Market Share (2018-2020)
Figure 160. Biotronik Chronic Heart Failure (CHF) Devices Market Share (2018-2020)
Figure 161. Cardiokinetix Chronic Heart Failure (CHF) Devices Market Share (2018-2020)
Figure 162. Jarvik Heart Chronic Heart Failure (CHF) Devices Market Share (2018-2020)
Figure 163. ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Market Share (2018-2020)
